BG104340A - 3'-n-модифицирани 6-о-заместени кетолидни производни на еритромицин, притежаващи антибактериална активност - Google Patents

3'-n-модифицирани 6-о-заместени кетолидни производни на еритромицин, притежаващи антибактериална активност

Info

Publication number
BG104340A
BG104340A BG104340A BG10434000A BG104340A BG 104340 A BG104340 A BG 104340A BG 104340 A BG104340 A BG 104340A BG 10434000 A BG10434000 A BG 10434000A BG 104340 A BG104340 A BG 104340A
Authority
BG
Bulgaria
Prior art keywords
modified
antibacterial activity
substituted erythromycin
erythromycin ketolide
ketolide derivatives
Prior art date
Application number
BG104340A
Other languages
English (en)
Inventor
Yat S. Or
Zhenkun Ma
Daniel T. Chu
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG104340A publication Critical patent/BG104340A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BG104340A 1997-09-30 2000-04-14 3'-n-модифицирани 6-о-заместени кетолидни производни на еритромицин, притежаващи антибактериална активност BG104340A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94087197A 1997-09-30 1997-09-30
US13312198A 1998-08-12 1998-08-12
PCT/US1998/019311 WO1999016779A1 (en) 1997-09-30 1998-09-16 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity

Publications (1)

Publication Number Publication Date
BG104340A true BG104340A (bg) 2001-01-31

Family

ID=26831064

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104340A BG104340A (bg) 1997-09-30 2000-04-14 3'-n-модифицирани 6-о-заместени кетолидни производни на еритромицин, притежаващи антибактериална активност

Country Status (22)

Country Link
EP (1) EP1025114B1 (bg)
JP (1) JP2001518476A (bg)
KR (1) KR20010030807A (bg)
CN (1) CN1271363A (bg)
AR (1) AR015727A1 (bg)
AT (1) ATE260293T1 (bg)
AU (1) AU737310B2 (bg)
BG (1) BG104340A (bg)
BR (1) BR9812577A (bg)
CA (1) CA2303930A1 (bg)
CO (1) CO4990958A1 (bg)
DE (1) DE69821964T2 (bg)
DK (1) DK1025114T3 (bg)
ES (1) ES2217579T3 (bg)
HU (1) HUP0004579A3 (bg)
IL (1) IL134608A0 (bg)
NO (1) NO20001439L (bg)
PL (1) PL339575A1 (bg)
PT (1) PT1025114E (bg)
SK (1) SK4562000A3 (bg)
TR (1) TR200000805T2 (bg)
WO (1) WO1999016779A1 (bg)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
ES2272273T3 (es) * 1999-04-16 2007-05-01 Kosan Biosciences, Inc. Agentes antiinfecciosos macrolidos.
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
EP1310506A4 (en) * 2000-08-14 2004-04-14 Taisho Pharmaceutical Co Ltd METHOD FOR PRODUCING AN ERYTHROMYCINE DERIVATIVE
US20020111317A1 (en) * 2000-09-25 2002-08-15 Leonard Katz Sixteen-membered macrolide compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
JP5383037B2 (ja) * 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
CN108101948A (zh) * 2004-02-27 2018-06-01 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006129257A2 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US8470985B2 (en) 2005-08-24 2013-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
US8278281B2 (en) * 2005-08-24 2012-10-02 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
EP1957508A2 (en) * 2005-11-23 2008-08-20 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US8124744B2 (en) * 2006-05-01 2012-02-28 Taisho Pharmaceutical Co., Ltd. Macrolide derivatives
WO2008099368A1 (en) * 2007-02-15 2008-08-21 Ranbaxy Laboratories Limited Macrolide derivatives as antibacterial agents
WO2008111020A2 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Macrolide derivatives as antibacterial agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
JP2000500133A (ja) * 1995-11-08 2000-01-11 アボツト・ラボラトリーズ 三環式エリスロマイシン誘導体

Also Published As

Publication number Publication date
WO1999016779A1 (en) 1999-04-08
NO20001439D0 (no) 2000-03-20
BR9812577A (pt) 2000-10-17
DE69821964D1 (de) 2004-04-01
TR200000805T2 (tr) 2000-10-23
KR20010030807A (ko) 2001-04-16
AR015727A1 (es) 2001-05-16
HUP0004579A2 (hu) 2001-05-28
ATE260293T1 (de) 2004-03-15
PT1025114E (pt) 2004-07-30
EP1025114B1 (en) 2004-02-25
AU9317698A (en) 1999-04-23
AU737310B2 (en) 2001-08-16
EP1025114A1 (en) 2000-08-09
DE69821964T2 (de) 2004-12-30
HUP0004579A3 (en) 2001-11-28
ES2217579T3 (es) 2004-11-01
NO20001439L (no) 2000-05-29
DK1025114T3 (da) 2004-07-05
CO4990958A1 (es) 2000-12-26
SK4562000A3 (en) 2000-09-12
PL339575A1 (en) 2000-12-18
IL134608A0 (en) 2001-04-30
CN1271363A (zh) 2000-10-25
JP2001518476A (ja) 2001-10-16
CA2303930A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
BG104340A (bg) 3'-n-модифицирани 6-о-заместени кетолидни производни на еритромицин, притежаващи антибактериална активност
BG104434A (bg) 2-хало-6-0-заместени кетолидни производни
CA2263972A1 (en) 6-o-substituted ketolides having antibacterial activity
CA2316919A1 (en) Novel macrolides
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
CA2253338A1 (en) 6-o-substituted erythromycins and method for making them
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
TR200001140T2 (tr) 6, 11-Köprülü eritromisin türevleri.
BR9812148A (pt) Derivados de eritromicina 6,9-ligados em ponte
WO2004011477A3 (en) 6,11-4-carbon bridged ketolides
CA2351429A1 (en) 13-membered azalides and their use as antibiotic agents
MX9803692A (es) Derivados de eritromicina triciclicos.
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
TW427906B (en) Antifungal compositions
BR9708929A (pt) Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
WO1999011651A3 (en) 3-descladinose 6-o-substituded erythromycin derivatives
WO2003089446A3 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
CA2380455A1 (en) 9a-azalides with antibacterial activity
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
CA2290421A1 (en) Multicyclic erythromycin derivatives
WO2004000864A3 (en) 11-c-substituted ketolides
CA2564020A1 (en) 6-o-substituted ketolides having antibacterial activity